In addition, the regulation of HIF-1α and GSH releases Tregs-induced immunosuppressive binding, thereby completely activating the immune anti-tumor response, providing a new immunomodulatory strategy from the perspective of redox regulation. Here, HIF1A is linked to neoplasm.